HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 21 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,000 | -50.0% | 22,700 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | +128.6% | 22,700 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -56.2% | 22,700 | 0.0% | 0.00% | – |
| Q4 2019 | $16,000 | -27.3% | 22,700 | -30.2% | 0.00% | – |
| Q3 2019 | $22,000 | -58.5% | 32,507 | +2.0% | 0.00% | – |
| Q2 2019 | $53,000 | -65.6% | 31,862 | -48.4% | 0.00% | – |
| Q1 2019 | $154,000 | +2.0% | 61,796 | +4.0% | 0.00% | – |
| Q4 2018 | $151,000 | +31.3% | 59,438 | +161.8% | 0.00% | – |
| Q3 2018 | $115,000 | +55.4% | 22,700 | 0.0% | 0.00% | – |
| Q2 2018 | $74,000 | -9.8% | 22,700 | 0.0% | 0.00% | – |
| Q1 2018 | $82,000 | -76.2% | 22,700 | -54.4% | 0.00% | – |
| Q1 2017 | $345,000 | – | 49,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 535,590 | $2,705,000 | 1.58% |
| Millrace Asset Group, Inc. | 200,000 | $1,010,000 | 0.79% |
| Private Wealth Partners, LLC | 1,000,000 | $5,050,000 | 0.77% |
| PERKINS CAPITAL MANAGEMENT INC | 249,700 | $1,261,000 | 0.76% |
| Timpani Capital Management LLC | 206,119 | $1,041,000 | 0.30% |
| Diametric Capital, LP | 64,329 | $325,000 | 0.28% |
| Granahan Investment Management | 941,170 | $4,753,000 | 0.26% |
| Kalos Management, Inc. | 69,900 | $308,000 | 0.16% |
| SYMMETRY PEAK MANAGEMENT LLC | 85,000 | $429,000 | 0.15% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $1,263,000 | 0.15% |